Precision Medicine Drives Oligonucleotide Synthesis Market to New Heights
The global oligonucleotide synthesis market is experiencing explosive growth, projected to surge from $8.8 billion in 2024 to a staggering $19.7 billion by 2029 at a compound annual growth rate of 17.5%. This meteoric rise is fueled by several key drivers. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350 Driving Forces Behind the Market's Ascent · Escalating use of synthesized oligonucleotides in therapeutic and diagnostic applications, harnessing their potential to tackle a diverse array of neurological disorders, rare diseases, and gene therapy. · Continuous technological advancements, such as next-generation sequencing (NGS) and the revolutionary CRISPR gene-editing tool, which are catalyzing demand for oligonucleotide synthesis. · Burgeoning investments from governments and major industry...